View More Recent Stories
-
IQVIA Holdings (IQV) PT Lowered to $265 at Truist Securities
-
IQVIA Holdings (IQV) PT Lowered to $255 at TD Cowen
-
IQVIA Holdings (IQV) PT Lowered to $260 at BTIG
-
IQVIA Holdings (IQV) PT Lowered to $235 at Evercore ISI
-
IQVIA Holdings (IQV) Tops Q3 EPS by 3c, provides guidance
-
IQVIA Holdings (IQV) PT Lowered to $270 at RBC Capital
-
IQVIA Holdings (IQV) PT Lowered to $270 at Deutsche Bank
-
Redburn-Atlantic Starts IQVIA Holdings (IQV) at Buy
-
IQVIA Holdings (IQV) 1400 contracts of October 230 puts trade
-
RBC Capital Starts IQVIA Holdings (IQV) at Outperform
-
Mizuho Reiterates Outperform Rating on IQVIA Holdings (IQV)
-
IQVIA Holdings (IQV) August 230, 240 and 250 calls active
-
Jefferies Downgrades IQVIA Holdings (IQV) to Hold
-
TD Cowen Reiterates Buy Rating on IQVIA Holdings (IQV)
-
IQVIA Holdings (IQV) PT Raised to $300 at Truist Securities
-
IQVIA Holdings (IQV) PT Raised to $251 at Baird
-
Deutsche Bank Reiterates Buy Rating on IQVIA Holdings (IQV)
-
BTIG Reiterates Buy Rating on IQVIA Holdings (IQV)
-
IQVIA Holdings (IQV) August 200 puts and Augusts 230 calls active as share price up 7%
-
IQVIA Holdings (IQV) Tops Q2 EPS by 7c ; Offers Guidance
-
Life Science Tools & Diagnostics stocks: Q2 earnings preview
-
IQVIA Holdings (IQV) PT Lowered to $235 at Baird
-
Deutsche Bank Reiterates Buy Rating on IQVIA Holdings (IQV)
-
IQVIA Holdings (IQV) PT Lowered to $241 at Baird

